TLR1
Basic information
Region (hg38): 4:38787555-38856817
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TLR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 16 | ||||
missense | 40 | 10 | 58 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 40 | 22 | 12 |
Variants in TLR1
This is a list of pathogenic ClinVar variants found in the TLR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-38792853-T-TTATATATATATATATATATATATATATATATA | Uncertain significance (-) | |||
4-38796523-G-C | not specified | Uncertain significance (Jan 31, 2023) | ||
4-38796548-T-C | not specified | Uncertain significance (Aug 30, 2021) | ||
4-38796601-T-C | not specified | Uncertain significance (Sep 22, 2022) | ||
4-38796673-T-G | Likely benign (May 01, 2023) | |||
4-38796683-T-A | not specified | Uncertain significance (Jan 22, 2024) | ||
4-38796685-T-C | not specified | Uncertain significance (Mar 24, 2023) | ||
4-38796695-A-C | not specified | Uncertain significance (Mar 31, 2024) | ||
4-38796740-A-C | not specified | Uncertain significance (Aug 02, 2021) | ||
4-38796760-T-C | not specified | Uncertain significance (Jun 29, 2023) | ||
4-38796778-G-A | not specified | Uncertain significance (Oct 04, 2022) | ||
4-38796796-A-G | Rheumatoid arthritis | Pathogenic (Nov 02, 2020) | ||
4-38796804-G-A | Benign/Likely benign (May 01, 2023) | |||
4-38796812-C-T | not provided (-) | |||
4-38796826-T-C | not specified | Uncertain significance (May 30, 2024) | ||
4-38796880-A-G | not provided (-) | |||
4-38796894-G-A | TLR1-related disorder | Benign (May 15, 2018) | ||
4-38796904-T-A | not specified | Uncertain significance (Dec 09, 2023) | ||
4-38796904-T-C | not specified | Uncertain significance (Aug 12, 2022) | ||
4-38796930-A-G | Likely benign (May 18, 2018) | |||
4-38796974-G-C | not specified | Uncertain significance (Oct 06, 2021) | ||
4-38797027-C-A | Leprosy, protection against • Leprosy, susceptibility to, 1 • TLR1-related disorder | Conflicting classifications of pathogenicity; protective (Jun 10, 2022) | ||
4-38797028-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
4-38797036-G-A | Uncertain significance (-) | |||
4-38797063-A-G | not specified | Uncertain significance (Feb 05, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TLR1 | protein_coding | protein_coding | ENST00000308979 | 1 | 66141 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.87e-23 | 0.0000283 | 125251 | 2 | 493 | 125746 | 0.00197 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.702 | 435 | 396 | 1.10 | 0.0000194 | 5247 |
Missense in Polyphen | 146 | 122.09 | 1.1958 | 1746 | ||
Synonymous | -0.827 | 167 | 154 | 1.08 | 0.00000800 | 1456 |
Loss of Function | -1.73 | 29 | 20.6 | 1.41 | 8.75e-7 | 318 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00177 | 0.00177 |
Ashkenazi Jewish | 0.00824 | 0.00787 |
East Asian | 0.00190 | 0.00190 |
Finnish | 0.00176 | 0.00176 |
European (Non-Finnish) | 0.00182 | 0.00154 |
Middle Eastern | 0.00190 | 0.00190 |
South Asian | 0.00354 | 0.00344 |
Other | 0.00295 | 0.00261 |
dbNSFP
Source:
- Function
- FUNCTION: Participates in the innate immune response to microbial agents. Specifically recognizes diacylated and triacylated lipopeptides. Cooperates with TLR2 to mediate the innate immune response to bacterial lipoproteins or lipopeptides (PubMed:21078852). Forms the activation cluster TLR2:TLR1:CD14 in response to triacylated lipopeptides, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway (PubMed:16880211). Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. {ECO:0000269|PubMed:16880211, ECO:0000269|PubMed:21078852}.;
- Pathway
- Toll-like receptor signaling pathway - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Regulation of toll-like receptor signaling pathway;IL1 and megakaryocytes in obesity;Toll-like Receptor Signaling;Simplified Depiction of MYD88 Distinct Input-Output Pathway;Toll-like Receptor Signaling Pathway;Toll-Like Receptors Cascades;Antimicrobial peptides;Innate Immune System;Immune System;Adaptive Immune System;Beta defensins;Antigen processing-Cross presentation;Class I MHC mediated antigen processing & presentation;Defensins;Regulation of TLR by endogenous ligand;ER-Phagosome pathway;Toll Like Receptor 4 (TLR4) Cascade;MyD88:Mal cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll Like Receptor 2 (TLR2) Cascade;Endogenous TLR signaling
(Consensus)
Recessive Scores
- pRec
- 0.354
Intolerance Scores
- loftool
- 0.963
- rvis_EVS
- 1.32
- rvis_percentile_EVS
- 94.07
Haploinsufficiency Scores
- pHI
- 0.0760
- hipred
- N
- hipred_score
- 0.327
- ghis
- 0.438
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.210
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tlr1
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- cell activation;toll-like receptor signaling pathway;MyD88-dependent toll-like receptor signaling pathway;inflammatory response;immune response;signal transduction;toll-like receptor 1 signaling pathway;positive regulation of toll-like receptor 2 signaling pathway;toll-like receptor TLR1:TLR2 signaling pathway;macrophage activation;detection of triacyl bacterial lipopeptide;positive regulation of tumor necrosis factor biosynthetic process;innate immune response;positive regulation of interleukin-6 biosynthetic process;cellular response to triacyl bacterial lipopeptide;positive regulation of interleukin-8 secretion
- Cellular component
- Golgi apparatus;plasma membrane;integral component of plasma membrane;membrane;phagocytic vesicle membrane;Toll-like receptor 1-Toll-like receptor 2 protein complex;membrane raft
- Molecular function
- transmembrane signaling receptor activity;protein binding;Toll-like receptor 2 binding;signaling receptor activity;identical protein binding;protein heterodimerization activity;lipopeptide binding